Research and Markets: Investigation Report on China's Meropenam (Sumitomo Pharmaceuticals) Market 2015-2019

Business News
Print
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/mw2pzz/investigation) has announced the addition of the "Investigation Report on China Meropenam Market, 2010-2019" report to their offering. Meropenam, developed together by Sumitomo Pharmaceuticals Co., Ltd and Imperial Chemical Industries Ltd, belongs to the second generation of broad- spectrum carbapenem and the first carbapenem which can be used alone. In 2014, the sales value of meropenam in the glob

imageimage
image